Utility of Cancer Value Frameworks for Patients, Payers, and Physicians
In recent years, novel cancer therapies have improved the expected survival of patients but have also increased treatment costs.
In recent years, novel cancer therapies have improved the expected survival of patients but have also increased treatment costs.
BACKGROUND: Physician in triage and rotational patient assignment are different front-end processes that are designed to improve patient flow, but there are little or no data comparing them. OBJECTIV
The introduction of generic second-generation anti-psychotics (SGAs), starting with risperidone in July 2008, could reduce antipsychotic spending and cost-related use barriers.
Drs Frankel and McKay first note that the FDA is able to ensure biosimilar and reference biologic quality through prerelease specifications.
The slow global response to the Ebola crisis in west Africa suggests that important gaps exist in donor financing for key global functions, such as support for health research and development for dise
Get smart & reliable public policy insights right in your inbox.